QuidelOrtho Balance Sheet
NASDAQ: QDELHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QuidelOrtho financial position
At the end of fiscal 2025, QuidelOrtho reported total assets of $5.77 billion, down 10.2% from a year earlier against total liabilities of $3.85 billion. Shareholders' equity stood at $1.92 billion, or 33.3% of assets. The company held $169.8 million in cash and equivalents against $2.65 billion of debt, a net debt position of $2.48 billion.
The current ratio (current assets divided by current liabilities) was 1.50, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.38.
Summary generated from market data by MetaCap's automated system. Methodology
QuidelOrtho balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20222022-01-02 | FY 20212021-01-03 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 169.80M | 98.30M | 118.90M | 292.90M | 802.80M | 489.90M |
| Short-Term Investments | — | 0 | 48.40M | 52.10M | 25.70M | — |
| Receivables | 417.00M | 282.40M | 303.30M | 453.90M | 378.00M | — |
| Inventory | 577.60M | 533.70M | 577.80M | 524.10M | 198.80M | — |
| Total Current Assets | 1.45B | 1.22B | 1.31B | 1.58B | 1.44B | — |
| Property, Plant & Equipment | 1.36B | 1.38B | 1.44B | 1.34B | 349.20M | — |
| Goodwill | 0 | 649.50M | 2.49B | 2.48B | 337.00M | — |
| Intangible Assets | 2.56B | 2.74B | 2.93B | 3.12B | 98.70M | — |
| Long-Term Investments | — | 0 | 7.40M | 21.00M | 37.90M | — |
| Total Assets | 5.77B | 6.42B | 8.56B | 8.86B | 2.43B | — |
| Accounts Payable | 279.40M | 246.00M | 294.80M | 283.30M | 101.50M | — |
| Short-Term Debt | 178.30M | 341.80M | 139.80M | 207.50M | 300.00K | — |
| Total Current Liabilities | 966.10M | 998.80M | 833.80M | 1.01B | 323.50M | — |
| Long-Term Debt | 2.47B | 2.14B | 2.27B | 2.43B | 700.00K | — |
| Total Liabilities | 3.85B | 3.44B | 3.56B | 3.92B | 501.00M | — |
| Shareholders' Equity | 1.92B | 2.98B | 5.01B | 4.93B | 1.93B | 1.33B |
| Retained Earnings | -996.00M | 135.80M | 2.19B | 2.20B | 1.65B | — |
| Total Debt | 2.65B | 2.48B | 2.41B | 2.64B | 1.00M | — |
| Net Cash (Debt) | -2.48B | -2.38B | -2.25B | -2.29B | 827.50M | 489.90M |
| Shares Outstanding | 67.90M | 67.30M | 66.70M | 66.40M | 41.70M | — |
This table shows 6 annual periods of QuidelOrtho's balance sheet, from FY 2025 back to FY 2021, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QDEL's reporting calendar. What is a balance sheet?